CoreCap Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.9K Sell
504
-130
-21% -$6.6K ﹤0.01% 1707
2026
Q1
$33.8K Sell
634
-50
-7% -$2.94K ﹤0.01% 1474
2025
Q4
$42.5K Sell
684
-8
-1% -$494 ﹤0.01% 1400
2025
Q3
$41.6K Hold
692
﹤0.01% 1396
2025
Q2
$43.4K Hold
692
﹤0.01% 1312
2025
Q1
$41.7K Buy
692
+4
+0.6% +$248 ﹤0.01% 1251
2024
Q4
$40.1K Buy
688
+10
+1% +$594 ﹤0.01% 1279
2024
Q3
$40.1K Buy
+678
New +$38.7K ﹤0.01% 1286
2024
Q2
Sell
-2,004
Closed -$117K 2069
2024
Q1
$117K Buy
+2,004
New +$113K 0.01% 782
2022
Q4
$190K Buy
+3,608
New +$183K 0.01% 549
2022
Q3
Sell
-3,483
Closed -$176K 1256
2022
Q2
$176K Sell
3,483
-1,290
-27% -$70.3K 0.01% 547
2022
Q1
$291K Sell
4,773
-479
-9% -$28.6K 0.02% 413
2021
Q4
$346K Buy
+5,252
New +$336K 0.02% 416

Other funds holding IHI

CoreCap Advisors's IHI Position: Q2 2026 in Review

CoreCap Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 21% in Q2 2026, selling an estimated $6.6K and leaving 504 shares worth $24.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1707.

CoreCap Advisors first reported a position in IHI in Q4 2021 and has held it in 13 quarters since. The position peaked at $346K in Q4 2021. 65 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • CoreCap Advisors held 504 shares of iShares US Medical Devices ETF worth $24.9K as of Q2 2026.
  • CoreCap Advisors sold 130 iShares US Medical Devices ETF shares in Q2 2026, an estimated $6.6K.
  • iShares US Medical Devices ETF made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1707 holding.
  • CoreCap Advisors first reported a position in iShares US Medical Devices ETF in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's iShares US Medical Devices ETF position peaked at $346K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.